Talecris Biotherapeutics Holdings Corp. 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Sep 7, 2010
Insider Transaction Report
Form 4
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
- Sale
Common Stock
2010-09-03$22.50/sh−113,440$2,552,400→ 21,120 total
Footnotes (2)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.